158 related articles for article (PubMed ID: 15832463)
1. Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis.
Golub JE; Bur S; Cronin WA; Gange S; Sterling TR; Oden B; Baruch N; Comstock GW; Chaisson RE
Int J Tuberc Lung Dis; 2005 Apr; 9(4):392-7. PubMed ID: 15832463
[TBL] [Abstract][Full Text] [Related]
2. Think TB! Is the diagnosis of pulmonary tuberculosis delayed by the use of antibiotics?
Craig SE; Bettinson H; Sabin CA; Gillespie SH; Lipman MC
Int J Tuberc Lung Dis; 2009 Feb; 13(2):208-13. PubMed ID: 19146749
[TBL] [Abstract][Full Text] [Related]
3. Patient and health care system delays in pulmonary tuberculosis diagnosis in a low-incidence state.
Golub JE; Bur S; Cronin WA; Gange S; Baruch N; Comstock GW; Chaisson RE
Int J Tuberc Lung Dis; 2005 Sep; 9(9):992-8. PubMed ID: 16158891
[TBL] [Abstract][Full Text] [Related]
4. Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis.
Long R; Chong H; Hoeppner V; Shanmuganathan H; Kowalewska-Grochowska K; Shandro C; Manfreda J; Senthilselvan A; Elzainy A; Marrie T
Clin Infect Dis; 2009 May; 48(10):1354-60. PubMed ID: 19348594
[TBL] [Abstract][Full Text] [Related]
5. Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia.
Yoon YS; Lee HJ; Yoon HI; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Int J Tuberc Lung Dis; 2005 Nov; 9(11):1215-9. PubMed ID: 16333927
[TBL] [Abstract][Full Text] [Related]
6. [Bone and joint tuberculosis concurrent with tuberculosis of other organs].
Yagi O; Kawabe Y; Nagayama N; Shimada M; Kawashima M; Kaneko Y; Ariga H; Ohshima N; Matsui Y; Suzuki J; Masuda K; Tamura A; Nagai H; Akagawa S; Machida K; Kurashima A; Nakajima Y; Yotsumoto H
Kekkaku; 2007 Jun; 82(6):523-9. PubMed ID: 17633120
[TBL] [Abstract][Full Text] [Related]
7. Identification of 90% of patients ultimately diagnosed with community-acquired pneumonia within four hours of emergency department arrival may not be feasible.
Fee C; Weber EJ
Ann Emerg Med; 2007 May; 49(5):553-9. PubMed ID: 17210202
[TBL] [Abstract][Full Text] [Related]
8. Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis.
Dooley KE; Golub J; Goes FS; Merz WG; Sterling TR
Clin Infect Dis; 2002 Jun; 34(12):1607-12. PubMed ID: 12032896
[TBL] [Abstract][Full Text] [Related]
9. Delayed tuberculosis diagnosis and tuberculosis transmission.
Golub JE; Bur S; Cronin WA; Gange S; Baruch N; Comstock GW; Chaisson RE
Int J Tuberc Lung Dis; 2006 Jan; 10(1):24-30. PubMed ID: 16466033
[TBL] [Abstract][Full Text] [Related]
10. Is the delay in diagnosis of pulmonary tuberculosis related to exposure to fluoroquinolones or any antibiotic?
Wang M; Fitzgerald JM; Richardson K; Marra CA; Cook VJ; Hajek J; Elwood RK; Bowie WR; Marra F
Int J Tuberc Lung Dis; 2011 Aug; 15(8):1062-8. PubMed ID: 21740669
[TBL] [Abstract][Full Text] [Related]
11. Barriers in accessing to tuberculosis care among non-residents in Shanghai: a descriptive study of delays in diagnosis.
Wang W; Jiang Q; Abdullah AS; Xu B
Eur J Public Health; 2007 Oct; 17(5):419-23. PubMed ID: 17412714
[TBL] [Abstract][Full Text] [Related]
12. Patient and health service delay in pulmonary tuberculosis patients attending a referral hospital: a cross-sectional study.
Kiwuwa MS; Charles K; Harriet MK
BMC Public Health; 2005 Nov; 5():122. PubMed ID: 16307685
[TBL] [Abstract][Full Text] [Related]
13. Continuity of antibiotic therapy in patients admitted from the emergency department.
Shah MN; Schmit J; Croley WC; Meltzer D
Ann Emerg Med; 2003 Jul; 42(1):117-23. PubMed ID: 12827131
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB).
Lavoie F; Blais L; Castilloux AM; Scalera A; LeLorier J
Can J Clin Pharmacol; 2005; 12(2):e212-7. PubMed ID: 15998960
[TBL] [Abstract][Full Text] [Related]
15. The effect of extracorporeal efferent detoxication (EED) methods inclusion in the severe community-acquired pneumonia (CAP) treatment.
Makarevich A; Pancratova J; Kyrkovsky V
Adv Med Sci; 2006; 51():73-87. PubMed ID: 17357282
[TBL] [Abstract][Full Text] [Related]
16. The impact of emergency department crowding measures on time to antibiotics for patients with community-acquired pneumonia.
Pines JM; Localio AR; Hollander JE; Baxt WG; Lee H; Phillips C; Metlay JP
Ann Emerg Med; 2007 Nov; 50(5):510-6. PubMed ID: 17913298
[TBL] [Abstract][Full Text] [Related]
17. Effect of a simple educational intervention on the hospital management of community-acquired pneumonia.
Serisier DJ; Bowler SD
Respirology; 2007 May; 12(3):389-93. PubMed ID: 17539843
[TBL] [Abstract][Full Text] [Related]
18. [Can macrolide treatment delay the diagnosis of tuberculosis?].
Gómez Cubillos C; Carrión Valero F; Pascual Izuel JM
An Med Interna; 1999 Jul; 16(7):385-6. PubMed ID: 10481348
[No Abstract] [Full Text] [Related]
19. Tuberculosis: still overlooked as a cause of community-acquired pneumonia--how not to miss it.
Kunimoto D; Long R
Respir Care Clin N Am; 2005 Mar; 11(1):25-34. PubMed ID: 15763219
[TBL] [Abstract][Full Text] [Related]
20. C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ.
Krüger S; Ewig S; Kunde J; Hanschmann A; Marre R; Suttorp N; Welte T;
J Antimicrob Chemother; 2009 Jul; 64(1):159-62. PubMed ID: 19403654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
